Pancreatic Cancer Research

ResearcherThe University of SydneyNo recent work listed

Emily K. Colvin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5435-5902; OpenAlex author ID A5056675811. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
42
Papers, trials and grants by year

2011: 2 papers · 2012: 2 papers · 2013: 1 paper · 2014: 2 papers · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 2 papers

Papers 15

  1. The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer. Co-author DOI 10.1007/s00432-023-05149-4↗
  2. The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as B… Co-author DOI 10.3390/jcm12051989↗
  3. The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resect… Co-author DOI 10.3390/cancers14153620↗
  4. Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000003143↗
  5. Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study. Co-author DOI 10.1016/j.ejso.2018.10.050↗
  6. Genomic analyses identify molecular subtypes of pancreatic cancer. Co-author DOI 10.1038/nature16965↗
  7. Whole genomes redefine the mutational landscape of pancreatic cancer. Co-author DOI 10.1038/nature14169↗
  8. The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa… First author DOI 10.3892/ijo.2015.2894↗
  9. A historical perspective of pancreatic cancer mouse models. Co-author DOI 10.1016/j.semcdb.2014.03.025↗
  10. Adjuvant chemotherapy in elderly patients with pancreatic cancer. Co-author DOI 10.1038/bjc.2013.722↗
  11. Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-12-3359↗
  12. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Co-author DOI 10.1038/nature11547↗
  13. The prognostic and predictive value of serum CA19.9 in pancreatic cancer. Co-author DOI 10.1093/annonc/mdr561↗
  14. Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interaction. First author DOI 10.1371/journal.pone.0026088↗
  15. Retinoid signaling in pancreatic cancer, injury and regeneration. Co-author DOI 10.1371/journal.pone.0029075↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jaswinder Singh Samra · 7 shared papers, 2012–2023 · strength 0.70
  2. Stephen John Clarke · 4 shared papers, 2019–2023 · strength 0.57
  3. Nick Pavlakis · 4 shared papers, 2019–2023 · strength 0.57
  4. Anubhav Mittal · 4 shared papers, 2019–2023 · strength 0.57
  5. Anthony James Gill · 6 shared papers, 2012–2023 · strength 0.51
  6. Sumit Sahni · 3 shared papers, 2022–2023 · strength 0.49
  7. Malinda Itchins · 3 shared papers, 2019–2023 · strength 0.38
  8. Sarah Maloney · 2 shared papers, 2023 · strength 0.35
  9. Christopher James Scarlett · 7 shared papers, 2011–2020 · strength 0.31
  10. Andrew Victor Biankin · 7 shared papers, 2011–2020 · strength 0.25
  11. Angela S. Y. Chou · 3 shared papers, 2014–2022 · strength 0.24
  12. David Kuang-Fu Chang · 6 shared papers, 2011–2020 · strength 0.22
  13. Christopher Bahdah Nahm · 2 shared papers, 2019–2022 · strength 0.22
  14. Marina Pajic · 5 shared papers, 2011–2020 · strength 0.20
  15. James G. Kench · 5 shared papers, 2011–2020 · strength 0.17
  16. David Lok Hang Chan · 1 shared paper, 2023 · strength 0.16
  17. Nigel Balfour Jamieson · 2 shared papers, 2019–2020 · strength 0.15
  18. Jeremy L. Humphris · 3 shared papers, 2012–2020 · strength 0.13
  19. Amber L. Johns · 3 shared papers, 2012–2020 · strength 0.13
  20. Venessa T. Chin · 3 shared papers, 2012–2020 · strength 0.13
  21. Lorraine A. Chantrill · 3 shared papers, 2012–2020 · strength 0.13
  22. Adnan M. Nagrial · 3 shared papers, 2012–2020 · strength 0.13
  23. Mark J. Cowley · 2 shared papers, 2013–2020 · strength 0.10
  24. Neil Donald Merrett · 2 shared papers, 2012–2020 · strength 0.10
  25. Stephan B. Dreyer · 1 shared paper, 2020 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.